1887

Abstract

Duck plague virus (DPV) is a virus of the family that leads to acute disease with a high mortality rate in ducks. Control of the disease contributes to the development of poultry breeding. Type III IFN family (IFN-λs) is a novel member of the IFN family, and goose IFN-λ (goIFN-λ) is a newly identified gene whose antiviral function has only been investigated to a limited extent. Here, the cross-species antiviral activity of goIFN-λ against DPV in duck embryo fibroblasts (DEFs) was studied. We found that pre-treatment with goIFN-λ greatly increased the expression of IFN-λ in both heterologous DEFs and homologous goose embryo fibroblasts (GEFs), while differentially inducing IFNα- and IFN-stimulated genes. Additionally, a positive self-regulatory feedback loop of goIFN-λ was blocked by a mouse anti-goIFN-λ polyclonal antibody, which was confirmed in both homologous GEFs and goose peripheral blood mononuclear cells (PBMCs). The suppression of the BAC-DPV-EGFP by goIFN-λ in DEFs was confirmed by fluorescence microscopy, flow cytometry (FCM) analysis, viral copies and titre detection, which can be rescued by mouse anti-goIFN-λ polyclonal antibody incubation. Finally, reporter gene assays indicated that the cross-species antiviral activity of goIFN-λ against BAC-DPV-EGFP is related to its positive self-regulatory feedback loop and subsequent ISG induction. Our data shed light on the fundamental mechanisms of goIFN-λ antiviral function and extend the considerable range of therapeutic applications in multiple-poultry disease

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.000788
2017-06-01
2019-12-11
Loading full text...

Full text loading...

/deliver/fulltext/jgv/98/6/1455.html?itemId=/content/journal/jgv/10.1099/jgv.0.000788&mimeType=html&fmt=ahah

References

  1. Lin FC, Young HA. Interferons: success in anti-viral immunotherapy. Cytokine Growth Factor Rev 2014;25:369–376 [CrossRef][PubMed]
    [Google Scholar]
  2. Schneider WM, Chevillotte MD, Rice CM. Interferon-stimulated genes: a complex web of host defenses. Annu Rev Immunol 2014;32:513–545 [CrossRef][PubMed]
    [Google Scholar]
  3. Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M et al. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 2003;4:69–77 [CrossRef][PubMed]
    [Google Scholar]
  4. Schoggins JW, Rice CM. Interferon-stimulated genes and their antiviral effector functions. Curr Opin Virol 2011;1:519–525 [CrossRef][PubMed]
    [Google Scholar]
  5. Travar M, Petkovic M, Verhaz A. Type I, II, and III interferons: regulating immunity to Mycobacterium tuberculosis infection. Arch Immunol Ther Exp 2016;64:19–31 [CrossRef][PubMed]
    [Google Scholar]
  6. de Weerd NA, Nguyen T. The interferons and their receptors—distribution and regulation. Immunol Cell Biol 2012;90:483–491 [CrossRef][PubMed]
    [Google Scholar]
  7. Prokunina-Olsson L, Muchmore B, Tang W, Pfeiffer RM, Park H et al. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet 2013;45:164–171 [CrossRef][PubMed]
    [Google Scholar]
  8. Zhou Z, Hamming OJ, Ank N, Paludan SR, Nielsen AL et al. Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases. J Virol 2007;81:7749–7758 [CrossRef][PubMed]
    [Google Scholar]
  9. Hermant P, Michiels T. Interferon-λ in the context of viral infections: production, response and therapeutic implications. J Innate Immun 2014;6:563–574 [CrossRef][PubMed]
    [Google Scholar]
  10. Ank N, West H, Paludan SR. IFN-λ: novel antiviral cytokines. J Interferon Cytokine Res 2006;26:373–379 [CrossRef][PubMed]
    [Google Scholar]
  11. Sommereyns C, Paul S, Staeheli P, Michiels T. IFN-lambda (IFN-λ) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog 2008;4:e1000017 [CrossRef][PubMed]
    [Google Scholar]
  12. Karpala AJ, Morris KR, Broadway MM, McWaters PG, O'Neil TE et al. Molecular cloning, expression, and characterization of chicken IFN-λ. J Interferon Cytokine Res 2008;28:341–350 [CrossRef][PubMed]
    [Google Scholar]
  13. Yao Q, Fischer KP, Arnesen K, Tyrrell DL, Gutfreund KS. Molecular cloning, expression and characterization of Pekin duck interferon-λ. Gene 2014;548:29–38 [CrossRef][PubMed]
    [Google Scholar]
  14. Reuter A, Soubies S, Härtle S, Schusser B, Kaspers B et al. Antiviral activity of lambda interferon in chickens. J Virol 2014;88:2835–2843 [CrossRef][PubMed]
    [Google Scholar]
  15. Masuda Y, Matsuda A, Usui T, Sugai T, Asano A et al. Biological effects of chicken type III interferon on expression of interferon-stimulated genes in chickens: comparison with type I and type II interferons. J Vet Med Sci 2012;74:1381–1386 [CrossRef][PubMed]
    [Google Scholar]
  16. Zhou Q, Zhang W, Chen S, Wang A, Sun L et al. Identification of Type III interferon (IFN-λ) in Chinese Goose: gene structure, age-dependent expression profile, and antiviral immune characteristics in vivo and in vitro. J Interferon Cytokine Res 2017;37:269–277 [CrossRef][PubMed]
    [Google Scholar]
  17. Zhou Q, Chen S, Qi Y, Zhou H, Wang M et al. Identification, characterization, and developmental expression pattern of type III interferon receptor gene in the Chinese goose. Biomed Res Int 2015;2015:1–11 [CrossRef][PubMed]
    [Google Scholar]
  18. Gad HH, Dellgren C, Hamming OJ, Vends S, Paludan SR et al. Interferon-λ is functionally an interferon but structurally related to the interleukin-10 family. J Biol Chem 2009;284:20869–20875 [CrossRef][PubMed]
    [Google Scholar]
  19. Lazear HM, Nice TJ, Diamond MS. Interferon-λ: immune functions at barrier surfaces and beyond. Immunity 2015;43:15–28 [CrossRef][PubMed]
    [Google Scholar]
  20. Tyrrell DA. Interferon produced by cultures of calf kidney cells. Nature 1959;184:452–453 [CrossRef][PubMed]
    [Google Scholar]
  21. Baron S, Barban S, Buckler CE. Host cell species specificity of mouse and chicken interferons. Science 1964;145:814 [CrossRef][PubMed]
    [Google Scholar]
  22. Buckler CE, Baron S. Antiviral action of mouse interferon in heterologous cells. J Bacteriol 1966;91:231–235[PubMed]
    [Google Scholar]
  23. Gifford GE. Studies on the specificity of interferon. J Gen Microbiol 1963;33:437–443 [CrossRef][PubMed]
    [Google Scholar]
  24. Merigan TC. Purified interferons: physical properties and species specificity. Science 1964;145:811–813 [CrossRef][PubMed]
    [Google Scholar]
  25. Takano K, Jensen KE, Warren J. Passive interferon protection in mouse influenza. Proc Soc Exp Biol Med 1963;114:472–475 [CrossRef][PubMed]
    [Google Scholar]
  26. Desmyter J, Rawls WE, Melnick JL. A human interferon that crosses the species line. Proc Natl Acad Sci USA 1968;59:69–76 [CrossRef][PubMed]
    [Google Scholar]
  27. Gresser I, Bandu MT, Brouty-Boye D, Tovey M. Pronounced antiviral activity of human interferon on bovine and porcine cells. Nature 1974;251:543–545 [CrossRef][PubMed]
    [Google Scholar]
  28. Fringuelli E, Urbanelli L, Tharuni O, Proietti PC, Bietta A et al. Cloning and expression of pigeon IFN-γ gene. Res Vet Sci 2010;89:367–372 [CrossRef][PubMed]
    [Google Scholar]
  29. Fan W, Xu L, Ren L, Qu H, Li J et al. Functional characterization of canine interferon-lambda. J Interferon Cytokine Res 2014;34:848–857 [CrossRef][PubMed]
    [Google Scholar]
  30. Zhou H, Chen S, Zhou Q, Wei Y, Wang M et al. Cross-species antiviral activity of goose interferons against duck plague virus is related to its positive self-feedback regulation and subsequent interferon stimulated genes induction. Viruses 2016;8:195 [CrossRef][PubMed]
    [Google Scholar]
  31. Ank N, West H, Bartholdy C, Eriksson K, Thomsen AR et al. Lambda interferon (IFN-λ), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J Virol 2006;80:4501–4509 [CrossRef][PubMed]
    [Google Scholar]
  32. Kindler E, Jónsdóttir HR, Muth D, Hamming OJ, Hartmann R et al. Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential. MBio 2013;4:e00611-1200611172 [CrossRef][PubMed]
    [Google Scholar]
  33. Brand S, Beigel F, Olszak T, Zitzmann K, Eichhorst ST et al. IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression. Am J Physiol Gastrointest Liver Physiol 2005;289:G960–G968 [CrossRef][PubMed]
    [Google Scholar]
  34. Liu B, McGilvray I, Chen L. IFN-λ: a new class of interferon with distinct functions-implications for hepatitis C virus research. Gastroenterol Res Pract 2015;2015:1–9 [CrossRef][PubMed]
    [Google Scholar]
  35. Robek MD, Boyd BS, Chisari FV. Lambda interferon inhibits hepatitis B and C virus replication. J Virol 2005;79:3851–3854 [CrossRef][PubMed]
    [Google Scholar]
  36. Lazear HM, Daniels BP, Pinto AK, Huang AC, Vick SC et al. Interferon-λ restricts West Nile virus neuroinvasion by tightening the blood-brain barrier. Sci Transl Med 2015;7:284ra59 [CrossRef][PubMed]
    [Google Scholar]
  37. Ma D, Jiang D, Qing M, Weidner JM, Qu X et al. Antiviral effect of interferon lambda against West Nile virus. Antiviral Res 2009;83:53–60 [CrossRef][PubMed]
    [Google Scholar]
  38. Palma-Ocampo HK, Flores-Alonso JC, Vallejo-Ruiz V, Reyes-Leyva J, Flores-Mendoza L et al. Interferon lambda inhibits dengue virus replication in epithelial cells. Virol J 2015;12:1–14 [CrossRef][PubMed]
    [Google Scholar]
  39. Lopušná K, Benkóczka T, Lupták J, Matúšková R, Lukáčiková Ľ et al. Murine gammaherpesvirus targets type I IFN receptor but not type III IFN receptor early in infection. Cytokine 2016;83:158–170 [CrossRef][PubMed]
    [Google Scholar]
  40. Perez-Martin E, Weiss M, Diaz-San Segundo F, Pacheco JM, Arzt J et al. Bovine type III interferon significantly delays and reduces the severity of foot-and-mouth disease in cattle. J Virol 2012;86:4477–4487 [CrossRef][PubMed]
    [Google Scholar]
  41. Jiang D, Weidner JM, Qing M, Pan XB, Guo H et al. Identification of five interferon-induced cellular proteins that inhibit West Nile virus and dengue virus infections. J Virol 2010;84:8332–8341 [CrossRef][PubMed]
    [Google Scholar]
  42. Sen GC. Viruses and interferons. Annu Rev Microbiol 2001;55:255–281 [CrossRef][PubMed]
    [Google Scholar]
  43. Pott J, Mahlakõiv T, Mordstein M, Duerr CU, Michiels T et al. IFN-λ determines the intestinal epithelial antiviral host defense. Proc Natl Acad Sci USA 2011;108:7944–7949 [CrossRef][PubMed]
    [Google Scholar]
  44. Schreiber G, Piehler J. The molecular basis for functional plasticity in type I interferon signaling. Trends Immunol 2015;36:139–149 [CrossRef][PubMed]
    [Google Scholar]
  45. Chen S, Zhao Q, Qi Y, Liu F, Wang M et al. Immunobiological activity and antiviral regulation efforts of Chinese goose (Anser cygnoides) CD8α during NGVEV and GPV infection. Poult Sci 2015;94:17–24 [CrossRef][PubMed]
    [Google Scholar]
  46. Zhou H, Chen S, Qi Y, Wang M, Jia R et al. Development and validation of a SYBR Green real-time PCR assay for rapid and quantitative detection of goose interferons and proinflammatory cytokines. Poult Sci 2015;94:2382–2387 [CrossRef][PubMed]
    [Google Scholar]
  47. Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. Am J Trop Med Hyg 1938;27:493–497
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.000788
Loading
/content/journal/jgv/10.1099/jgv.0.000788
Loading

Data & Media loading...

Supplements

Supplementary File 1

PDF

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error